nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C8—Mometasone—atopic dermatitis	0.076	0.108	CbGbCtD
Lapatinib—CYP3A5—Tacrolimus—atopic dermatitis	0.062	0.0885	CbGbCtD
Lapatinib—CYP2C8—Loratadine—atopic dermatitis	0.0436	0.0623	CbGbCtD
Lapatinib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0407	0.058	CbGbCtD
Lapatinib—ABCB1—Tacrolimus—atopic dermatitis	0.0404	0.0576	CbGbCtD
Lapatinib—CYP2C19—Loratadine—atopic dermatitis	0.0366	0.0523	CbGbCtD
Lapatinib—CYP2C19—Diphenhydramine—atopic dermatitis	0.0366	0.0523	CbGbCtD
Lapatinib—ABCB1—Loratadine—atopic dermatitis	0.0295	0.0422	CbGbCtD
Lapatinib—ABCB1—Methylprednisolone—atopic dermatitis	0.027	0.0386	CbGbCtD
Lapatinib—CYP3A5—Hydrocortisone—atopic dermatitis	0.0253	0.036	CbGbCtD
Lapatinib—CYP2C8—Hydrocortisone—atopic dermatitis	0.0243	0.0346	CbGbCtD
Lapatinib—CYP3A4—Tacrolimus—atopic dermatitis	0.0242	0.0345	CbGbCtD
Lapatinib—CYP2C19—Prednisone—atopic dermatitis	0.0203	0.029	CbGbCtD
Lapatinib—CYP3A4—Loratadine—atopic dermatitis	0.0177	0.0253	CbGbCtD
Lapatinib—ABCB1—Betamethasone—atopic dermatitis	0.0176	0.0251	CbGbCtD
Lapatinib—ABCB1—Prednisolone—atopic dermatitis	0.0173	0.0247	CbGbCtD
Lapatinib—ABCB1—Hydrocortisone—atopic dermatitis	0.0164	0.0235	CbGbCtD
Lapatinib—ABCB1—Prednisone—atopic dermatitis	0.0164	0.0234	CbGbCtD
Lapatinib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0162	0.0231	CbGbCtD
Lapatinib—CYP3A5—Dexamethasone—atopic dermatitis	0.0157	0.0224	CbGbCtD
Lapatinib—CYP2C8—Dexamethasone—atopic dermatitis	0.0151	0.0215	CbGbCtD
Lapatinib—CYP2C19—Dexamethasone—atopic dermatitis	0.0127	0.0181	CbGbCtD
Lapatinib—CYP3A4—Triamcinolone—atopic dermatitis	0.0123	0.0175	CbGbCtD
Lapatinib—CYP3A4—Betamethasone—atopic dermatitis	0.0105	0.015	CbGbCtD
Lapatinib—CYP3A4—Prednisolone—atopic dermatitis	0.0104	0.0148	CbGbCtD
Lapatinib—ABCB1—Dexamethasone—atopic dermatitis	0.0102	0.0146	CbGbCtD
Lapatinib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00985	0.0141	CbGbCtD
Lapatinib—CYP3A4—Prednisone—atopic dermatitis	0.00981	0.014	CbGbCtD
Lapatinib—CYP3A4—Dexamethasone—atopic dermatitis	0.00612	0.00874	CbGbCtD
Lapatinib—ERBB2—Everolimus—Pimecrolimus—atopic dermatitis	0.000837	0.105	CbGdCrCtD
Lapatinib—ERBB2—Everolimus—Tacrolimus—atopic dermatitis	0.000837	0.105	CbGdCrCtD
Lapatinib—Dermatitis—Pimecrolimus—atopic dermatitis	0.000438	0.00218	CcSEcCtD
Lapatinib—Abdominal pain—Loratadine—atopic dermatitis	0.000438	0.00218	CcSEcCtD
Lapatinib—Headache—Pimecrolimus—atopic dermatitis	0.000436	0.00217	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000433	0.00215	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00043	0.00214	CcSEcCtD
Lapatinib—Anaemia—Tacrolimus—atopic dermatitis	0.000429	0.00213	CcSEcCtD
Lapatinib—Nausea—Diphenhydramine—atopic dermatitis	0.000427	0.00212	CcSEcCtD
Lapatinib—Nausea—Dimenhydrinate—atopic dermatitis	0.000427	0.00212	CcSEcCtD
Lapatinib—Dyspnoea—Mometasone—atopic dermatitis	0.000424	0.00211	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.000424	0.0021	CcSEcCtD
Lapatinib—Cardiac failure—Betamethasone—atopic dermatitis	0.000421	0.00209	CcSEcCtD
Lapatinib—Cardiac failure—Dexamethasone—atopic dermatitis	0.000421	0.00209	CcSEcCtD
Lapatinib—Dyspepsia—Mometasone—atopic dermatitis	0.000419	0.00208	CcSEcCtD
Lapatinib—Leukopenia—Tacrolimus—atopic dermatitis	0.000415	0.00206	CcSEcCtD
Lapatinib—Decreased appetite—Mometasone—atopic dermatitis	0.000413	0.00205	CcSEcCtD
Lapatinib—Nausea—Pimecrolimus—atopic dermatitis	0.000413	0.00205	CcSEcCtD
Lapatinib—Fatigue—Mometasone—atopic dermatitis	0.00041	0.00204	CcSEcCtD
Lapatinib—Palpitations—Tacrolimus—atopic dermatitis	0.00041	0.00204	CcSEcCtD
Lapatinib—Cough—Tacrolimus—atopic dermatitis	0.000405	0.00201	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.000398	0.00198	CcSEcCtD
Lapatinib—Asthenia—Loratadine—atopic dermatitis	0.000398	0.00198	CcSEcCtD
Lapatinib—Arthralgia—Tacrolimus—atopic dermatitis	0.000395	0.00196	CcSEcCtD
Lapatinib—Myalgia—Tacrolimus—atopic dermatitis	0.000395	0.00196	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000392	0.00195	CcSEcCtD
Lapatinib—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000389	0.00193	CcSEcCtD
Lapatinib—Diarrhoea—Loratadine—atopic dermatitis	0.000379	0.00188	CcSEcCtD
Lapatinib—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000378	0.00188	CcSEcCtD
Lapatinib—Dry skin—Dexamethasone—atopic dermatitis	0.000376	0.00187	CcSEcCtD
Lapatinib—Dry skin—Betamethasone—atopic dermatitis	0.000376	0.00187	CcSEcCtD
Lapatinib—Infection—Tacrolimus—atopic dermatitis	0.000376	0.00187	CcSEcCtD
Lapatinib—Abdominal pain—Mometasone—atopic dermatitis	0.000376	0.00187	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisolone—atopic dermatitis	0.000372	0.00185	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Desonide—atopic dermatitis	0.000371	0.0466	CbGdCrCtD
Lapatinib—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000371	0.00184	CcSEcCtD
Lapatinib—Infestation—Hydrocortisone—atopic dermatitis	0.00037	0.00184	CcSEcCtD
Lapatinib—Infestation NOS—Hydrocortisone—atopic dermatitis	0.00037	0.00184	CcSEcCtD
Lapatinib—Skin disorder—Tacrolimus—atopic dermatitis	0.000368	0.00183	CcSEcCtD
Lapatinib—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000367	0.00182	CcSEcCtD
Lapatinib—Cardiac failure—Prednisone—atopic dermatitis	0.000366	0.00182	CcSEcCtD
Lapatinib—Neuropathy peripheral—Hydrocortisone—atopic dermatitis	0.000363	0.0018	CcSEcCtD
Lapatinib—Anorexia—Tacrolimus—atopic dermatitis	0.000361	0.00179	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Desonide—atopic dermatitis	0.000353	0.0442	CbGdCrCtD
Lapatinib—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000352	0.00175	CcSEcCtD
Lapatinib—Vomiting—Loratadine—atopic dermatitis	0.000352	0.00175	CcSEcCtD
Lapatinib—Rash—Loratadine—atopic dermatitis	0.000349	0.00174	CcSEcCtD
Lapatinib—Dermatitis—Loratadine—atopic dermatitis	0.000349	0.00173	CcSEcCtD
Lapatinib—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000348	0.00173	CcSEcCtD
Lapatinib—Infestation—Methylprednisolone—atopic dermatitis	0.000348	0.00173	CcSEcCtD
Lapatinib—Headache—Loratadine—atopic dermatitis	0.000347	0.00172	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000345	0.00171	CcSEcCtD
Lapatinib—Insomnia—Tacrolimus—atopic dermatitis	0.000342	0.0017	CcSEcCtD
Lapatinib—Neuropathy peripheral—Triamcinolone—atopic dermatitis	0.000342	0.0017	CcSEcCtD
Lapatinib—Asthenia—Mometasone—atopic dermatitis	0.000341	0.0017	CcSEcCtD
Lapatinib—Neuropathy peripheral—Methylprednisolone—atopic dermatitis	0.000341	0.00169	CcSEcCtD
Lapatinib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000341	0.00169	CcSEcCtD
Lapatinib—Dyspnoea—Tacrolimus—atopic dermatitis	0.000337	0.00168	CcSEcCtD
Lapatinib—Pruritus—Mometasone—atopic dermatitis	0.000336	0.00167	CcSEcCtD
Lapatinib—Dyspepsia—Tacrolimus—atopic dermatitis	0.000333	0.00166	CcSEcCtD
Lapatinib—Nausea—Loratadine—atopic dermatitis	0.000329	0.00164	CcSEcCtD
Lapatinib—Decreased appetite—Tacrolimus—atopic dermatitis	0.000329	0.00163	CcSEcCtD
Lapatinib—Epistaxis—Triamcinolone—atopic dermatitis	0.000329	0.00163	CcSEcCtD
Lapatinib—Dry skin—Prednisone—atopic dermatitis	0.000328	0.00163	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000327	0.00162	CcSEcCtD
Lapatinib—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000327	0.00162	CcSEcCtD
Lapatinib—Fatigue—Tacrolimus—atopic dermatitis	0.000326	0.00162	CcSEcCtD
Lapatinib—Diarrhoea—Mometasone—atopic dermatitis	0.000325	0.00162	CcSEcCtD
Lapatinib—Constipation—Tacrolimus—atopic dermatitis	0.000324	0.00161	CcSEcCtD
Lapatinib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000317	0.00157	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000315	0.00157	CcSEcCtD
Lapatinib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000314	0.00156	CcSEcCtD
Lapatinib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000314	0.00156	CcSEcCtD
Lapatinib—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000312	0.00155	CcSEcCtD
Lapatinib—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.00031	0.00154	CcSEcCtD
Lapatinib—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.00031	0.00154	CcSEcCtD
Lapatinib—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000309	0.00154	CcSEcCtD
Lapatinib—PIK3C2B—Exemestane—Methylprednisolone—atopic dermatitis	0.000307	0.0385	CbGdCrCtD
Lapatinib—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000307	0.00152	CcSEcCtD
Lapatinib—Vomiting—Mometasone—atopic dermatitis	0.000302	0.0015	CcSEcCtD
Lapatinib—Immune system disorder—Hydrocortisone—atopic dermatitis	0.0003	0.00149	CcSEcCtD
Lapatinib—Rash—Mometasone—atopic dermatitis	0.0003	0.00149	CcSEcCtD
Lapatinib—Dermatitis—Mometasone—atopic dermatitis	0.0003	0.00149	CcSEcCtD
Lapatinib—Abdominal pain—Tacrolimus—atopic dermatitis	0.000299	0.00149	CcSEcCtD
Lapatinib—Headache—Mometasone—atopic dermatitis	0.000298	0.00148	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Fluocinonide—atopic dermatitis	0.000297	0.0373	CbGdCrCtD
Lapatinib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000296	0.00147	CcSEcCtD
Lapatinib—Mental disorder—Hydrocortisone—atopic dermatitis	0.000291	0.00145	CcSEcCtD
Lapatinib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.00029	0.00144	CcSEcCtD
Lapatinib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000289	0.00144	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Fluocinolone Acetonide—atopic dermatitis	0.000289	0.0362	CbGdCrCtD
Lapatinib—Neutropenia—Prednisone—atopic dermatitis	0.000289	0.00144	CcSEcCtD
Lapatinib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000283	0.00141	CcSEcCtD
Lapatinib—Nausea—Mometasone—atopic dermatitis	0.000282	0.0014	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Fluocinonide—atopic dermatitis	0.000282	0.0354	CbGdCrCtD
Lapatinib—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000282	0.0014	CcSEcCtD
Lapatinib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000281	0.0014	CcSEcCtD
Lapatinib—PIK3C2B—Exemestane—Prednisone—atopic dermatitis	0.00028	0.0351	CbGdCrCtD
Lapatinib—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000279	0.00139	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Fluocinolone Acetonide—atopic dermatitis	0.000274	0.0344	CbGdCrCtD
Lapatinib—Mental disorder—Methylprednisolone—atopic dermatitis	0.000274	0.00136	CcSEcCtD
Lapatinib—PIK3C2B—Exemestane—Prednisolone—atopic dermatitis	0.000273	0.0343	CbGdCrCtD
Lapatinib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000272	0.00135	CcSEcCtD
Lapatinib—Asthenia—Tacrolimus—atopic dermatitis	0.000272	0.00135	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisone—atopic dermatitis	0.00027	0.00134	CcSEcCtD
Lapatinib—Pruritus—Tacrolimus—atopic dermatitis	0.000268	0.00133	CcSEcCtD
Lapatinib—Back pain—Triamcinolone—atopic dermatitis	0.000263	0.00131	CcSEcCtD
Lapatinib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000259	0.00129	CcSEcCtD
Lapatinib—Angiopathy—Betamethasone—atopic dermatitis	0.000258	0.00128	CcSEcCtD
Lapatinib—Angiopathy—Dexamethasone—atopic dermatitis	0.000258	0.00128	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Methylprednisolone—atopic dermatitis	0.000253	0.0317	CbGdCrCtD
Lapatinib—Alopecia—Betamethasone—atopic dermatitis	0.000251	0.00125	CcSEcCtD
Lapatinib—Alopecia—Dexamethasone—atopic dermatitis	0.000251	0.00125	CcSEcCtD
Lapatinib—Myalgia—Hydrocortisone—atopic dermatitis	0.000246	0.00122	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000245	0.00122	CcSEcCtD
Lapatinib—Connective tissue disorder—Prednisone—atopic dermatitis	0.000243	0.00121	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000242	0.0012	CcSEcCtD
Lapatinib—Vomiting—Tacrolimus—atopic dermatitis	0.000241	0.0012	CcSEcCtD
Lapatinib—Rash—Tacrolimus—atopic dermatitis	0.000239	0.00119	CcSEcCtD
Lapatinib—Dermatitis—Tacrolimus—atopic dermatitis	0.000238	0.00118	CcSEcCtD
Lapatinib—Cough—Triamcinolone—atopic dermatitis	0.000238	0.00118	CcSEcCtD
Lapatinib—Headache—Tacrolimus—atopic dermatitis	0.000237	0.00118	CcSEcCtD
Lapatinib—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000236	0.00117	CcSEcCtD
Lapatinib—Infection—Hydrocortisone—atopic dermatitis	0.000235	0.00117	CcSEcCtD
Lapatinib—Myalgia—Triamcinolone—atopic dermatitis	0.000232	0.00115	CcSEcCtD
Lapatinib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000232	0.00115	CcSEcCtD
Lapatinib—Myalgia—Methylprednisolone—atopic dermatitis	0.000231	0.00115	CcSEcCtD
Lapatinib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000231	0.00115	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Prednisone—atopic dermatitis	0.000231	0.0289	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Mometasone—atopic dermatitis	0.000231	0.0289	CbGdCrCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00023	0.00114	CcSEcCtD
Lapatinib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000229	0.00114	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Prednisolone—atopic dermatitis	0.000225	0.0282	CbGdCrCtD
Lapatinib—Anorexia—Hydrocortisone—atopic dermatitis	0.000225	0.00112	CcSEcCtD
Lapatinib—Nausea—Tacrolimus—atopic dermatitis	0.000225	0.00112	CcSEcCtD
Lapatinib—Angiopathy—Prednisone—atopic dermatitis	0.000224	0.00111	CcSEcCtD
Lapatinib—Immune system disorder—Prednisone—atopic dermatitis	0.000223	0.00111	CcSEcCtD
Lapatinib—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000222	0.0011	CcSEcCtD
Lapatinib—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000222	0.0011	CcSEcCtD
Lapatinib—Infection—Triamcinolone—atopic dermatitis	0.000221	0.0011	CcSEcCtD
Lapatinib—Infection—Methylprednisolone—atopic dermatitis	0.00022	0.00109	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Mometasone—atopic dermatitis	0.000219	0.0275	CbGdCrCtD
Lapatinib—Insomnia—Prednisolone—atopic dermatitis	0.000219	0.00109	CcSEcCtD
Lapatinib—Alopecia—Prednisone—atopic dermatitis	0.000218	0.00109	CcSEcCtD
Lapatinib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000218	0.00108	CcSEcCtD
Lapatinib—Mental disorder—Prednisone—atopic dermatitis	0.000217	0.00108	CcSEcCtD
Lapatinib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000215	0.00107	CcSEcCtD
Lapatinib—Malnutrition—Prednisone—atopic dermatitis	0.000215	0.00107	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000215	0.00107	CcSEcCtD
Lapatinib—Insomnia—Hydrocortisone—atopic dermatitis	0.000214	0.00106	CcSEcCtD
Lapatinib—Myalgia—Dexamethasone—atopic dermatitis	0.00021	0.00105	CcSEcCtD
Lapatinib—Myalgia—Betamethasone—atopic dermatitis	0.00021	0.00105	CcSEcCtD
Lapatinib—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000208	0.00103	CcSEcCtD
Lapatinib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000205	0.00102	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000204	0.00101	CcSEcCtD
Lapatinib—Fatigue—Hydrocortisone—atopic dermatitis	0.000204	0.00101	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000203	0.00101	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000202	0.001	CcSEcCtD
Lapatinib—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000202	0.001	CcSEcCtD
Lapatinib—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000202	0.001	CcSEcCtD
Lapatinib—Insomnia—Triamcinolone—atopic dermatitis	0.000201	0.000999	CcSEcCtD
Lapatinib—Insomnia—Methylprednisolone—atopic dermatitis	0.000201	0.000997	CcSEcCtD
Lapatinib—Infection—Betamethasone—atopic dermatitis	0.0002	0.000996	CcSEcCtD
Lapatinib—Infection—Dexamethasone—atopic dermatitis	0.0002	0.000996	CcSEcCtD
Lapatinib—Anaemia—Prednisone—atopic dermatitis	0.000199	0.000988	CcSEcCtD
Lapatinib—Dyspnoea—Triamcinolone—atopic dermatitis	0.000198	0.000985	CcSEcCtD
Lapatinib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000198	0.000983	CcSEcCtD
Lapatinib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000198	0.000983	CcSEcCtD
Lapatinib—Dyspepsia—Triamcinolone—atopic dermatitis	0.000196	0.000972	CcSEcCtD
Lapatinib—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000195	0.00097	CcSEcCtD
Lapatinib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000193	0.000959	CcSEcCtD
Lapatinib—Anorexia—Betamethasone—atopic dermatitis	0.000192	0.000955	CcSEcCtD
Lapatinib—Anorexia—Dexamethasone—atopic dermatitis	0.000192	0.000955	CcSEcCtD
Lapatinib—Fatigue—Triamcinolone—atopic dermatitis	0.000192	0.000952	CcSEcCtD
Lapatinib—Fatigue—Methylprednisolone—atopic dermatitis	0.000191	0.00095	CcSEcCtD
Lapatinib—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000187	0.000927	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000184	0.000913	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000184	0.000913	CcSEcCtD
Lapatinib—Myalgia—Prednisone—atopic dermatitis	0.000183	0.00091	CcSEcCtD
Lapatinib—Arthralgia—Prednisone—atopic dermatitis	0.000183	0.00091	CcSEcCtD
Lapatinib—Insomnia—Betamethasone—atopic dermatitis	0.000182	0.000906	CcSEcCtD
Lapatinib—Insomnia—Dexamethasone—atopic dermatitis	0.000182	0.000906	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000182	0.000904	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000181	0.000901	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisolone—atopic dermatitis	0.000178	0.000885	CcSEcCtD
Lapatinib—Dyspepsia—Dexamethasone—atopic dermatitis	0.000178	0.000882	CcSEcCtD
Lapatinib—Dyspepsia—Betamethasone—atopic dermatitis	0.000178	0.000882	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisone—atopic dermatitis	0.000176	0.000873	CcSEcCtD
Lapatinib—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000175	0.000871	CcSEcCtD
Lapatinib—Decreased appetite—Dexamethasone—atopic dermatitis	0.000175	0.000871	CcSEcCtD
Lapatinib—Decreased appetite—Betamethasone—atopic dermatitis	0.000175	0.000871	CcSEcCtD
Lapatinib—Infection—Prednisone—atopic dermatitis	0.000175	0.000867	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000174	0.000865	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000174	0.000865	CcSEcCtD
Lapatinib—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000174	0.000864	CcSEcCtD
Lapatinib—Fatigue—Betamethasone—atopic dermatitis	0.000174	0.000864	CcSEcCtD
Lapatinib—Fatigue—Dexamethasone—atopic dermatitis	0.000174	0.000864	CcSEcCtD
Lapatinib—Nervous system disorder—Prednisone—atopic dermatitis	0.000172	0.000856	CcSEcCtD
Lapatinib—Skin disorder—Prednisone—atopic dermatitis	0.000171	0.000848	CcSEcCtD
Lapatinib—Asthenia—Hydrocortisone—atopic dermatitis	0.000169	0.000842	CcSEcCtD
Lapatinib—Anorexia—Prednisone—atopic dermatitis	0.000167	0.000832	CcSEcCtD
Lapatinib—Pruritus—Hydrocortisone—atopic dermatitis	0.000167	0.00083	CcSEcCtD
Lapatinib—PIK3C2B—Testosterone Propionate—Hydrocortisone—atopic dermatitis	0.000165	0.0207	CbGdCrCtD
Lapatinib—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000165	0.00082	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000165	0.00082	CcSEcCtD
Lapatinib—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000164	0.000814	CcSEcCtD
Lapatinib—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000163	0.000812	CcSEcCtD
Lapatinib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000162	0.000803	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.00016	0.000795	CcSEcCtD
Lapatinib—Asthenia—Triamcinolone—atopic dermatitis	0.00016	0.000792	CcSEcCtD
Lapatinib—Abdominal pain—Dexamethasone—atopic dermatitis	0.000159	0.000792	CcSEcCtD
Lapatinib—Abdominal pain—Betamethasone—atopic dermatitis	0.000159	0.000792	CcSEcCtD
Lapatinib—Asthenia—Methylprednisolone—atopic dermatitis	0.000159	0.000791	CcSEcCtD
Lapatinib—Insomnia—Prednisone—atopic dermatitis	0.000159	0.000789	CcSEcCtD
Lapatinib—Pruritus—Triamcinolone—atopic dermatitis	0.000157	0.000781	CcSEcCtD
Lapatinib—Pruritus—Methylprednisolone—atopic dermatitis	0.000157	0.00078	CcSEcCtD
Lapatinib—Dyspepsia—Prednisone—atopic dermatitis	0.000155	0.000768	CcSEcCtD
Lapatinib—Decreased appetite—Prednisone—atopic dermatitis	0.000153	0.000759	CcSEcCtD
Lapatinib—Rash—Prednisolone—atopic dermatitis	0.000152	0.000757	CcSEcCtD
Lapatinib—Dermatitis—Prednisolone—atopic dermatitis	0.000152	0.000757	CcSEcCtD
Lapatinib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000152	0.000754	CcSEcCtD
Lapatinib—Fatigue—Prednisone—atopic dermatitis	0.000151	0.000752	CcSEcCtD
Lapatinib—Headache—Prednisolone—atopic dermatitis	0.000151	0.000752	CcSEcCtD
Lapatinib—Constipation—Prednisone—atopic dermatitis	0.00015	0.000746	CcSEcCtD
Lapatinib—Vomiting—Hydrocortisone—atopic dermatitis	0.00015	0.000746	CcSEcCtD
Lapatinib—Rash—Hydrocortisone—atopic dermatitis	0.000149	0.00074	CcSEcCtD
Lapatinib—Dermatitis—Hydrocortisone—atopic dermatitis	0.000149	0.000739	CcSEcCtD
Lapatinib—Headache—Hydrocortisone—atopic dermatitis	0.000148	0.000735	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Hydrocortisone—atopic dermatitis	0.000146	0.0183	CbGdCrCtD
Lapatinib—Asthenia—Betamethasone—atopic dermatitis	0.000145	0.000719	CcSEcCtD
Lapatinib—Asthenia—Dexamethasone—atopic dermatitis	0.000145	0.000719	CcSEcCtD
Lapatinib—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000144	0.000714	CcSEcCtD
Lapatinib—Nausea—Prednisolone—atopic dermatitis	0.000144	0.000713	CcSEcCtD
Lapatinib—Pruritus—Dexamethasone—atopic dermatitis	0.000143	0.000709	CcSEcCtD
Lapatinib—Pruritus—Betamethasone—atopic dermatitis	0.000143	0.000709	CcSEcCtD
Lapatinib—Vomiting—Triamcinolone—atopic dermatitis	0.000141	0.000702	CcSEcCtD
Lapatinib—Vomiting—Methylprednisolone—atopic dermatitis	0.000141	0.000701	CcSEcCtD
Lapatinib—Nausea—Hydrocortisone—atopic dermatitis	0.00014	0.000697	CcSEcCtD
Lapatinib—Rash—Triamcinolone—atopic dermatitis	0.00014	0.000696	CcSEcCtD
Lapatinib—Dermatitis—Triamcinolone—atopic dermatitis	0.00014	0.000696	CcSEcCtD
Lapatinib—Rash—Methylprednisolone—atopic dermatitis	0.00014	0.000695	CcSEcCtD
Lapatinib—Dermatitis—Methylprednisolone—atopic dermatitis	0.00014	0.000694	CcSEcCtD
Lapatinib—Headache—Triamcinolone—atopic dermatitis	0.000139	0.000692	CcSEcCtD
Lapatinib—Headache—Methylprednisolone—atopic dermatitis	0.000139	0.00069	CcSEcCtD
Lapatinib—Abdominal pain—Prednisone—atopic dermatitis	0.000139	0.00069	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Hydrocortisone—atopic dermatitis	0.000139	0.0174	CbGdCrCtD
Lapatinib—Diarrhoea—Dexamethasone—atopic dermatitis	0.000138	0.000686	CcSEcCtD
Lapatinib—Diarrhoea—Betamethasone—atopic dermatitis	0.000138	0.000686	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Methylprednisolone—atopic dermatitis	0.000138	0.0173	CbGdCrCtD
Lapatinib—PIK3C2B—Danazol—Hydrocortisone—atopic dermatitis	0.000137	0.0172	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Betamethasone—atopic dermatitis	0.000136	0.017	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Dexamethasone—atopic dermatitis	0.000136	0.017	CbGdCrCtD
Lapatinib—Nausea—Triamcinolone—atopic dermatitis	0.000132	0.000656	CcSEcCtD
Lapatinib—Nausea—Methylprednisolone—atopic dermatitis	0.000132	0.000655	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Methylprednisolone—atopic dermatitis	0.000131	0.0164	CbGdCrCtD
Lapatinib—Hypersensitivity—Prednisone—atopic dermatitis	0.000129	0.000643	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Betamethasone—atopic dermatitis	0.000129	0.0161	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Dexamethasone—atopic dermatitis	0.000129	0.0161	CbGdCrCtD
Lapatinib—Vomiting—Betamethasone—atopic dermatitis	0.000128	0.000637	CcSEcCtD
Lapatinib—Vomiting—Dexamethasone—atopic dermatitis	0.000128	0.000637	CcSEcCtD
Lapatinib—Rash—Betamethasone—atopic dermatitis	0.000127	0.000632	CcSEcCtD
Lapatinib—Rash—Dexamethasone—atopic dermatitis	0.000127	0.000632	CcSEcCtD
Lapatinib—Dermatitis—Betamethasone—atopic dermatitis	0.000127	0.000631	CcSEcCtD
Lapatinib—Dermatitis—Dexamethasone—atopic dermatitis	0.000127	0.000631	CcSEcCtD
Lapatinib—Headache—Dexamethasone—atopic dermatitis	0.000126	0.000628	CcSEcCtD
Lapatinib—Headache—Betamethasone—atopic dermatitis	0.000126	0.000628	CcSEcCtD
Lapatinib—Asthenia—Prednisone—atopic dermatitis	0.000126	0.000626	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Triamcinolone—atopic dermatitis	0.000126	0.0158	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Prednisone—atopic dermatitis	0.000126	0.0158	CbGdCrCtD
Lapatinib—Pruritus—Prednisone—atopic dermatitis	0.000124	0.000617	CcSEcCtD
Lapatinib—PIK3C2B—Norethindrone—Hydrocortisone—atopic dermatitis	0.000124	0.0155	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Prednisolone—atopic dermatitis	0.000123	0.0154	CbGdCrCtD
Lapatinib—Diarrhoea—Prednisone—atopic dermatitis	0.00012	0.000597	CcSEcCtD
Lapatinib—Nausea—Betamethasone—atopic dermatitis	0.00012	0.000595	CcSEcCtD
Lapatinib—Nausea—Dexamethasone—atopic dermatitis	0.00012	0.000595	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisone—atopic dermatitis	0.000119	0.015	CbGdCrCtD
Lapatinib—PIK3C2B—Danazol—Prednisone—atopic dermatitis	0.000118	0.0148	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Prednisolone—atopic dermatitis	0.000116	0.0146	CbGdCrCtD
Lapatinib—Vomiting—Prednisone—atopic dermatitis	0.000112	0.000555	CcSEcCtD
Lapatinib—Rash—Prednisone—atopic dermatitis	0.000111	0.00055	CcSEcCtD
Lapatinib—Dermatitis—Prednisone—atopic dermatitis	0.000111	0.00055	CcSEcCtD
Lapatinib—Headache—Prednisone—atopic dermatitis	0.00011	0.000547	CcSEcCtD
Lapatinib—Nausea—Prednisone—atopic dermatitis	0.000104	0.000518	CcSEcCtD
Lapatinib—PIK3C2B—Levonorgestrel—Hydrocortisone—atopic dermatitis	9.84e-05	0.0123	CbGdCrCtD
Lapatinib—ERBB2—Signaling by ERBB2—IL6—atopic dermatitis	9.41e-05	0.00104	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—MAPK8—atopic dermatitis	9.4e-05	0.00104	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KIF3A—atopic dermatitis	9.4e-05	0.00104	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CASP1—atopic dermatitis	9.36e-05	0.00104	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—IL6—atopic dermatitis	9.36e-05	0.00104	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—IL6—atopic dermatitis	9.36e-05	0.00104	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—IL6—atopic dermatitis	9.31e-05	0.00103	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—IL6—atopic dermatitis	9.27e-05	0.00103	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—MAPK8—atopic dermatitis	9.26e-05	0.00103	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KIF3A—atopic dermatitis	9.25e-05	0.00103	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	9.23e-05	0.00102	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CASP1—atopic dermatitis	9.22e-05	0.00102	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—IL6—atopic dermatitis	9.22e-05	0.00102	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL1B—atopic dermatitis	9.06e-05	0.00101	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL2—atopic dermatitis	9.03e-05	0.001	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	9.02e-05	0.001	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL5—atopic dermatitis	8.88e-05	0.000986	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—IL6—atopic dermatitis	8.81e-05	0.000978	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	8.81e-05	0.000978	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—IL6—atopic dermatitis	8.81e-05	0.000978	CbGpPWpGaD
Lapatinib—EGFR—Immune System—DEFB1—atopic dermatitis	8.79e-05	0.000976	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—NGF—atopic dermatitis	8.78e-05	0.000975	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL5—atopic dermatitis	8.74e-05	0.000971	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—IL6—atopic dermatitis	8.73e-05	0.00097	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	8.68e-05	0.000964	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—IL6—atopic dermatitis	8.68e-05	0.000964	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—IL6—atopic dermatitis	8.68e-05	0.000964	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—IL6—atopic dermatitis	8.65e-05	0.000961	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL17—atopic dermatitis	8.63e-05	0.000958	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—IL6—atopic dermatitis	8.62e-05	0.000957	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—IL6—atopic dermatitis	8.6e-05	0.000955	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—NFKBIA—atopic dermatitis	8.54e-05	0.000949	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—IL6—atopic dermatitis	8.52e-05	0.000947	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CMA1—atopic dermatitis	8.5e-05	0.000944	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCL11—atopic dermatitis	8.5e-05	0.000944	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—IL6—atopic dermatitis	8.49e-05	0.000942	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TLR2—atopic dermatitis	8.47e-05	0.00094	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.43e-05	0.000936	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—NFKBIA—atopic dermatitis	8.42e-05	0.000935	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCL11—atopic dermatitis	8.37e-05	0.000929	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CMA1—atopic dermatitis	8.37e-05	0.000929	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TLR2—atopic dermatitis	8.34e-05	0.000926	CbGpPWpGaD
Lapatinib—TAP1—Immune System—MAPK8—atopic dermatitis	8.31e-05	0.000923	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—NFKBIA—atopic dermatitis	8.2e-05	0.000911	CbGpPWpGaD
Lapatinib—ERBB2—Levonorgestrel—Hydrocortisone—atopic dermatitis	8.1e-05	0.0102	CbGdCrCtD
Lapatinib—ERBB4—Adaptive Immune System—NFKBIA—atopic dermatitis	8.08e-05	0.000898	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—STAT6—atopic dermatitis	7.99e-05	0.000887	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD79A—atopic dermatitis	7.96e-05	0.000884	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—STAT6—atopic dermatitis	7.87e-05	0.000874	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	7.85e-05	0.000871	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD79A—atopic dermatitis	7.84e-05	0.000871	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	7.8e-05	0.000866	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CASP1—atopic dermatitis	7.77e-05	0.000863	CbGpPWpGaD
Lapatinib—EGFR—Disease—GLB1—atopic dermatitis	7.74e-05	0.00086	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CASP8—atopic dermatitis	7.71e-05	0.000856	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	7.69e-05	0.000853	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CASP8—atopic dermatitis	7.59e-05	0.000843	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—IL1B—atopic dermatitis	7.58e-05	0.000842	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.53e-05	0.000836	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TNF—atopic dermatitis	7.3e-05	0.000811	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	7.3e-05	0.00081	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—NFKBIA—atopic dermatitis	7.24e-05	0.000804	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	7.16e-05	0.000795	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TLR2—atopic dermatitis	7.03e-05	0.000781	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KIF3A—atopic dermatitis	7.03e-05	0.00078	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	7e-05	0.000777	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL2—atopic dermatitis	6.97e-05	0.000774	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL11—atopic dermatitis	6.95e-05	0.000772	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—MAPK8—atopic dermatitis	6.95e-05	0.000772	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCR3—atopic dermatitis	6.93e-05	0.000769	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	6.9e-05	0.000766	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FCER2—atopic dermatitis	6.86e-05	0.000761	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCR3—atopic dermatitis	6.82e-05	0.000758	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	6.67e-05	0.000741	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL18—atopic dermatitis	6.52e-05	0.000724	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD8A—atopic dermatitis	6.42e-05	0.000713	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL18—atopic dermatitis	6.42e-05	0.000713	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL22—atopic dermatitis	6.37e-05	0.000708	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD79A—atopic dermatitis	6.35e-05	0.000705	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD4—atopic dermatitis	6.33e-05	0.000703	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD8A—atopic dermatitis	6.32e-05	0.000702	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—MAPK8—atopic dermatitis	6.3e-05	0.0007	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	6.28e-05	0.000697	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD4—atopic dermatitis	6.23e-05	0.000692	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TAC1—atopic dermatitis	6.17e-05	0.000686	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NPS—atopic dermatitis	6.17e-05	0.000686	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NPS—atopic dermatitis	6.08e-05	0.000675	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TAC1—atopic dermatitis	6.08e-05	0.000675	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD4—atopic dermatitis	6.08e-05	0.000675	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCR3—atopic dermatitis	6.05e-05	0.000672	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—IL6—atopic dermatitis	6e-05	0.000666	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD4—atopic dermatitis	5.99e-05	0.000665	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT6—atopic dermatitis	5.97e-05	0.000663	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCR3—atopic dermatitis	5.96e-05	0.000662	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—IL6—atopic dermatitis	5.91e-05	0.000656	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL6—atopic dermatitis	5.89e-05	0.000654	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CARD11—atopic dermatitis	5.81e-05	0.000645	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL5—atopic dermatitis	5.74e-05	0.000637	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL27—atopic dermatitis	5.68e-05	0.000631	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCR3—atopic dermatitis	5.67e-05	0.00063	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL5—atopic dermatitis	5.65e-05	0.000628	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—atopic dermatitis	5.5e-05	0.000611	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—IL6—atopic dermatitis	5.43e-05	0.000603	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CCR5—atopic dermatitis	5.42e-05	0.000602	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—MAPK8—atopic dermatitis	5.36e-05	0.000595	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CCR5—atopic dermatitis	5.34e-05	0.000593	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL6—atopic dermatitis	5.31e-05	0.000589	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—PPARA—atopic dermatitis	5.29e-05	0.000587	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—MAPK8—atopic dermatitis	5.28e-05	0.000586	CbGpPWpGaD
Lapatinib—EGFR—Disease—SLC11A1—atopic dermatitis	5.19e-05	0.000576	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD8A—atopic dermatitis	5.12e-05	0.000568	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—IL6—atopic dermatitis	5.11e-05	0.000567	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL17—atopic dermatitis	5.1e-05	0.000566	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—atopic dermatitis	5.08e-05	0.000564	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TAC1—atopic dermatitis	5.05e-05	0.000561	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—NPS—atopic dermatitis	5.05e-05	0.000561	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	5.05e-05	0.000561	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NFKBIA—atopic dermatitis	4.98e-05	0.000553	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.97e-05	0.000551	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCR3—atopic dermatitis	4.95e-05	0.00055	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NFKBIA—atopic dermatitis	4.9e-05	0.000544	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL10—atopic dermatitis	4.89e-05	0.000543	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—atopic dermatitis	4.89e-05	0.000543	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL10—atopic dermatitis	4.82e-05	0.000535	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—atopic dermatitis	4.81e-05	0.000534	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—atopic dermatitis	4.8e-05	0.000533	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL5—atopic dermatitis	4.7e-05	0.000522	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.68e-05	0.00052	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—atopic dermatitis	4.59e-05	0.00051	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—atopic dermatitis	4.57e-05	0.000508	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	4.55e-05	0.000506	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—atopic dermatitis	4.55e-05	0.000505	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—MAPK8—atopic dermatitis	4.54e-05	0.000505	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KIF3A—atopic dermatitis	4.54e-05	0.000504	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CASP1—atopic dermatitis	4.53e-05	0.000503	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—atopic dermatitis	4.53e-05	0.000503	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CASP8—atopic dermatitis	4.49e-05	0.000499	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CASP8—atopic dermatitis	4.42e-05	0.000491	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GLB1—atopic dermatitis	4.34e-05	0.000482	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL5—atopic dermatitis	4.29e-05	0.000477	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—atopic dermatitis	4.26e-05	0.000473	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	4.26e-05	0.000473	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—atopic dermatitis	4.26e-05	0.000473	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—atopic dermatitis	4.22e-05	0.000469	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCL5—atopic dermatitis	4.21e-05	0.000468	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—atopic dermatitis	4.18e-05	0.000465	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—atopic dermatitis	4.16e-05	0.000463	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ADSL—atopic dermatitis	4.16e-05	0.000462	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCL5—atopic dermatitis	4.15e-05	0.000461	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NFKBIA—atopic dermatitis	4.13e-05	0.000459	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL11—atopic dermatitis	4.11e-05	0.000456	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CMA1—atopic dermatitis	4.11e-05	0.000456	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR2—atopic dermatitis	4.09e-05	0.000455	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL10—atopic dermatitis	4.01e-05	0.000445	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NFKBIA—atopic dermatitis	3.97e-05	0.00044	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NGF—atopic dermatitis	3.9e-05	0.000433	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—atopic dermatitis	3.88e-05	0.00043	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT6—atopic dermatitis	3.86e-05	0.000429	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD79A—atopic dermatitis	3.85e-05	0.000427	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NGF—atopic dermatitis	3.84e-05	0.000427	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFNG—atopic dermatitis	3.82e-05	0.000424	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCR5—atopic dermatitis	3.8e-05	0.000421	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	3.77e-05	0.000419	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFNG—atopic dermatitis	3.76e-05	0.000418	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GLB1—atopic dermatitis	3.76e-05	0.000417	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCR5—atopic dermatitis	3.74e-05	0.000415	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CASP8—atopic dermatitis	3.73e-05	0.000414	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—atopic dermatitis	3.69e-05	0.000409	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.65e-05	0.000405	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—atopic dermatitis	3.63e-05	0.000403	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ADSL—atopic dermatitis	3.6e-05	0.0004	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL5—atopic dermatitis	3.45e-05	0.000383	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—atopic dermatitis	3.42e-05	0.00038	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—atopic dermatitis	3.4e-05	0.000378	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—atopic dermatitis	3.4e-05	0.000378	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—atopic dermatitis	3.39e-05	0.000377	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—atopic dermatitis	3.37e-05	0.000374	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—atopic dermatitis	3.35e-05	0.000372	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—atopic dermatitis	3.35e-05	0.000372	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GLB1—atopic dermatitis	3.35e-05	0.000372	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR3—atopic dermatitis	3.35e-05	0.000372	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—atopic dermatitis	3.34e-05	0.000371	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GLB1—atopic dermatitis	3.27e-05	0.000363	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NFKBIA—atopic dermatitis	3.22e-05	0.000357	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ADSL—atopic dermatitis	3.21e-05	0.000357	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NFKBIA—atopic dermatitis	3.17e-05	0.000352	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.17e-05	0.000352	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL18—atopic dermatitis	3.15e-05	0.00035	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ADSL—atopic dermatitis	3.14e-05	0.000348	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MAPK8—atopic dermatitis	3.12e-05	0.000347	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCR5—atopic dermatitis	3.11e-05	0.000345	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—atopic dermatitis	3.1e-05	0.000345	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MAPK8—atopic dermatitis	3.08e-05	0.000341	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—atopic dermatitis	3.06e-05	0.00034	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TAC1—atopic dermatitis	2.98e-05	0.000331	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NPS—atopic dermatitis	2.98e-05	0.000331	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—atopic dermatitis	2.94e-05	0.000326	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCR3—atopic dermatitis	2.93e-05	0.000325	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—atopic dermatitis	2.9e-05	0.000322	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL5—atopic dermatitis	2.77e-05	0.000308	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.74e-05	0.000304	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—atopic dermatitis	2.63e-05	0.000292	CbGpPWpGaD
Lapatinib—EGFR—Disease—CCR5—atopic dermatitis	2.62e-05	0.000291	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MAPK8—atopic dermatitis	2.59e-05	0.000288	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.51e-05	0.000278	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.44e-05	0.000271	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NFKBIA—atopic dermatitis	2.41e-05	0.000267	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL10—atopic dermatitis	2.37e-05	0.000263	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—atopic dermatitis	2.32e-05	0.000258	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL8—atopic dermatitis	2.29e-05	0.000255	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.27e-05	0.000252	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL8—atopic dermatitis	2.26e-05	0.000251	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—atopic dermatitis	2.19e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CASP8—atopic dermatitis	2.17e-05	0.000241	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—atopic dermatitis	2.16e-05	0.00024	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL5—atopic dermatitis	2.04e-05	0.000226	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAPK8—atopic dermatitis	2.02e-05	0.000224	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.02e-05	0.000224	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—atopic dermatitis	1.99e-05	0.000221	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAPK8—atopic dermatitis	1.99e-05	0.000221	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—atopic dermatitis	1.96e-05	0.000218	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.93e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NGF—atopic dermatitis	1.89e-05	0.000209	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL8—atopic dermatitis	1.88e-05	0.000209	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—atopic dermatitis	1.87e-05	0.000208	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—atopic dermatitis	1.85e-05	0.000205	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—atopic dermatitis	1.84e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR5—atopic dermatitis	1.83e-05	0.000204	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—atopic dermatitis	1.81e-05	0.000201	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—atopic dermatitis	1.79e-05	0.000199	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—atopic dermatitis	1.78e-05	0.000198	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—atopic dermatitis	1.65e-05	0.000184	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—atopic dermatitis	1.65e-05	0.000183	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—atopic dermatitis	1.65e-05	0.000183	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—atopic dermatitis	1.64e-05	0.000182	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NFKBIA—atopic dermatitis	1.56e-05	0.000173	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK8—atopic dermatitis	1.51e-05	0.000168	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARA—atopic dermatitis	1.41e-05	0.000156	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—atopic dermatitis	1.29e-05	0.000143	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—atopic dermatitis	1.27e-05	0.000141	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.22e-05	0.000135	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL8—atopic dermatitis	1.11e-05	0.000123	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.09e-05	0.000121	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARA—atopic dermatitis	1.06e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—atopic dermatitis	1.06e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—atopic dermatitis	1.05e-05	0.000117	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK8—atopic dermatitis	9.76e-06	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—atopic dermatitis	9.64e-06	0.000107	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—atopic dermatitis	8.9e-06	9.88e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARA—atopic dermatitis	6.54e-06	7.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—atopic dermatitis	6.23e-06	6.92e-05	CbGpPWpGaD
